Novel BET Protein Proteolysis Targeting Chimeras (BETP-PROTACs®) Exert Potent Single Agent and Synergistic Activity with Ibrutinib and Venetoclax Against Human Mantle Cell Lymphoma Cells
American Society of Hematology 58th Annual Meeting and Exposition